Nephrogen
Curative gene therapies for kidney diseases
Gene Therapy
CRISPR
Biotech
About
Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Details
Status
Active
Stage
Early
Team Size
1
Regions
United States of America, America / Canada